Regeneron Pharmaceuticals announced on Tuesday that it is proceeding with a multi‑stage plan to bring a new biotech facility online in Saratoga Springs in 2026. The company said the project will broaden the region’s biotechnology footprint and generate employment opportunities.
The multi‑stage process outlined by Regeneron includes site preparation, construction phases, and the installation of research and production capabilities. Each phase will be completed sequentially, allowing the company to assess progress and adjust resources as needed before moving to the next step. The timeline targets a fully operational facility by the end of 2026.
Local officials have expressed support for the development, noting that an additional biotech hub could diversify the city’s economic base. The anticipated expansion aligns with recent trends of increased investment in life‑science infrastructure throughout upstate New York, where several firms have established laboratories and manufacturing sites in the past decade.
Regeneron’s decision to locate the new center in Saratoga Springs reflects the company’s strategy to leverage regional talent pools and existing research networks. While specific job numbers have not been disclosed, the company indicated that the project will create a range of positions, from construction and engineering roles during the build‑out to scientific and operational staff once the facility becomes active. The initiative is expected to contribute to the local labor market and reinforce the city’s growing reputation as a biotech corridor.